Latest Health News

Pro Medicus Limited has delivered a record-breaking FY2025 with soaring profits and a wave of major US healthcare contracts, setting the stage for continued expansion.

Viva Leisure Limited reported a strong financial performance for FY2025 with a 30% revenue increase and a 61% rise in net profit, yet chose not to declare dividends. The company’s audited results highlight growth amid cautious capital management.

Thrive Tribe Technologies has raised approximately $250,000 through a discounted share placement and repaid nearly $100,000 in loans by issuing shares, aiming to bolster working capital.

Orora Limited reported solid FY25 financial results driven by strong performance in its Cans business and the Saverglass acquisition, alongside key capacity expansions and glass network optimizations. The company’s robust balance sheet supports ongoing shareholder returns and a positive outlook for FY26.

OMG Group has secured placement of its Blue Dinosaur products in 750 7-Eleven stores nationwide, marking a pivotal step in its multi-channel expansion strategy and following record quarterly cash receipts.

Orezone Gold Corporation reported robust Q2 and H1 2025 results driven by higher gold production and prices, while advancing its Bomboré mine expansion and debuting on the ASX.

Telstra Group Limited has announced an additional $1 billion on-market share buy-back following a recent $750 million program, underscoring its strong financial position and commitment to shareholder returns.

Westpac Banking Corporation reported a robust 14% increase in statutory net profit for 3Q25, supported by disciplined growth and resilient credit quality. The bank’s capital and liquidity metrics remain comfortably above regulatory requirements, underscoring its financial strength.

Vista Group International reports robust H1 2025 results with strong revenue growth and margin expansion, driven by accelerating client adoption of its Vista Cloud platform and a new Embedded Payments initiative.

HomeCo Daily Needs REIT reported a robust financial year ending June 2025, with profit after tax soaring 205% to $250.3 million and steady distributions maintained. The REIT’s portfolio value and operational metrics reflect a resilient strategy in metro-located retail assets.

Pacific Smiles Group Limited reported a sharp 75.5% drop in statutory profit for FY 2025 due to one-off takeover expenses, yet underlying profit surged 38.6% on solid revenue growth and operational improvements.

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.